-
November 13: The Week in Cancer NewsA survey indicates that the pandemic is reducing cancer patients' willingness to enroll in cancer clinical trials, and a study find that indoor tanning increases risk of developing melanoma multiple times.
by Kate Yandell
-
November 6: The Week in Cancer NewsCancer survivors who use the internet for health-related reasons are more likely to be dissatisfied with their care, and liquid biopsy could misidentify which prostate cancer patients could benefit from targeted therapy.
by Kate Yandell
-
October 30: The Week in Cancer NewsThe U.S. Preventive Services Task Force releases draft guidance suggesting lowering the age at which people should begin routine colorectal cancer screening, and an ovarian cancer patient considers what clinical trials owe participants.
by Kate Yandell
-
October 23: The Week in Cancer NewsA newly discovered set of salivary glands could have implications for protecting head and neck cancer patients from radiation side effects, and younger melanoma patients respond better to a targeted therapy than older patients.
by Kate Yandell
-
October 16: The Week in Cancer NewsA study finds that some commercially insured patients getting screening colonoscopies receive a bill for out-of-network services, and a machine learning algorithm helps nudge oncology clinicians to talk about prognosis and the end of life.
by Kate Yandell
-
October 9: The Week in Cancer NewsA study finds that more than half of cancer patients participate in clinical trials when asked, and an annual survey sheds light on cancer patients' experience of the coronavirus pandemic.
by Kate Yandell
-
October 2: The Week in Cancer NewsA study finds that human papillomavirus vaccination reduces the rate of cervical cancer, and pediatric cancer researchers identify tradeoffs between reducing recurrence risk and minimizing long-term effects of treatment.
by Kate Yandell
-
September 25: The Week in Cancer NewsA trial shows that a form of targeted chemotherapy lengthens life for people with metastatic, triple-negative breast cancer, and researchers release more data on targeting KRAS-mutated lung cancer.
by Kate Yandell
-
Cancer Diagnoses and Research ContinueAmid the ongoing pandemic, Cancer Today continues to cover cancer research and treatment while also reporting on the many ways COVID-19 has impacted people with cancer.
by Kevin McLaughlin
-
September 18: The Week in Cancer NewsA report finds that more progress is needed to reduce cancer health disparities, and a study indicates that drinking large amounts of coffee may slightly lengthen survival for people with advanced or metastatic colorectal cancer.
by Kate Yandell
Challenges in developing and studying treatments call for new ways of thinking about cancer research.
by Eric Fitzsimmons
Treating Smoldering Multiple MyelomaA monoclonal antibody drug reduced the risk of smoldering myeloma progressing to multiple myeloma in patients at high risk for disease progression.
by Sandra Gordon
Immunotherapy Improves Survival in Bladder CancerNew research indicates that adding immunotherapy to muscle-invasive bladder cancer treatment can improve event-free and overall survival.
by Laura Gesualdi-Gilmore
Cancer Patients Who Quit Smoking, Even Years After Diagnosis, Live LongerFindings from a recent study support smoking cessation after diagnosis, with the most pronounced effect in those who received treatment within six months of diagnosis.
by Kyle Bagenstose
-
AACR IO: Revolutionizing Treatment through ImmunotherapyThe AACR’s immuno-oncology meeting brings together the leading experts in immunotherapy to accelerate progress in cancer science and medicine.
-
A New Resource Provides a Sanctuary for Black TNBC PatientsThe Black TNBC Sanctuary was created to help Black women with triple-negative breast cancer get answers about their diagnosis and care.
Dr. Humberto M. Guiot: Targeting Pancreatic Cancer in a Community-Based Clinical Trial
